November 4, 2024
Sanguine Biosciences is pleased to announce the launch of LeukoCert™, GMP-grade leukopaks designed for cell therapy manufacturing.
Sanguine Biosciences is pleased to announce the launch of LeukoCert™, GMP-grade leukopaks designed for cell therapy manufacturing.